C4 Therapeutics was founded in 2015 and is headquartered in Watertown, Massachusetts, USA. The company develops innovative candidate therapies that target and degrade proteins that cause diseases, for the treatment of cancer, neurodegenerative diseases, and other ailments. They have successfully developed orally bioavailable small molecule degrader drugs that utilize the body's natural protein recycling system to rapidly eliminate disease-causing proteins.C4 Therapeutics was founded in 2015 and is headquartered in Watertown, Massachusetts, USA. The company develops innovative candidate therapies that target and degrade proteins that cause diseases, for the treatment of cancer, neurodegenerative diseases, and other ailments. They have successfully developed orally bioavailable small molecule degrader drugs that utilize the body's natural protein recycling system to rapidly eliminate disease-causing proteins.